Abgenix to Webcast Participation in SunTrust Robinson Humphrey 'Off the Cuff' Therapeutics Conference
2/23/2005 4:30:11 PM
FREMONT, Calif., Feb 23, 2005 /PRNewswire-FirstCall via COMTEX/ -- Abgenix, Inc. (ABGX) today announced that the company will participate at the SunTrust Robinson Humphrey "Off The Cuff" Therapeutics Conference on Tuesday, March 1, 2005 at 12:15 p.m. PT, 3:15 p.m. ET. The presentation will be webcast live and may be accessed by visiting the Abgenix website at www.abgenix.com. A replay of the webcast will also be available on the company's website until Wednesday, March 15, 2005.
Dr. Gisela Schwab, chief medical officer of Abgenix, and H. Ward Wolff, chief financial officer, will discuss the company's antibody drug development activities.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through its own development efforts and through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at www.abgenix.com.
SOURCE Abgenix, Inc.
Ami Knoefler, Senior Director, Corporate Communications and Investor Relations of
Abgenix, Inc., +1-510-284-6350 or +1-510-284-6605 |
